Skip to content
Open access

Laparoscopic para-aortic and pelvic lymphadenectomy before chemoradiotherapy was not associated with improved survival in patients with FIGO stage IIB–IIIC cervical cancer: a single-center retrospective study

Oct 2026 · Frontiers in Oncology · Vol 16 · 0 citations · 37 references
Medicine

TL;DR

Laroscopic para-aortic and pelvic lymphadenectomy before chemoradiotherapy was not associated with improved PFS or OS in this retrospective cohort, and Tumor histology, pelvic wall involvement, and imaging-positive lymph nodes were the main prognostic factors.

Abstract

Background Currently, whether surgical staging can confer a survival benefit in patients with cervical cancer remains controversial, and its efficacy is similarly uncertain across different subgroups. The primary aim of this study was to assess the efficacy of laparoscopic para-aortic and pelvic lymphadenectomy prior to chemoradiotherapy in patients with International Federation of Gynecology and Obstetrics (FIGO) stage IIB–IIIC cervical cancer. The secondary aim was to identify the main prognostic factors. Methods A total of 396 patients were included in this retrospective study, 97 patients who underwent laparoscopic para-aortic and pelvic lymphadenectomy before chemoradiotherapy comprised the surgical staging group, and 299 patients who received chemoradiotherapy alone comprised the clinical staging group. Kaplan-Meier and log-rank methods were used to construct and compare progression-free survival (PFS) and overall survival (OS) curves, respectively. Multivariable Cox proportional hazards regression models were used to identify independent prognostic factors. Results There were no statistically significant differences in PFS (p = 0.187) or OS (p = 0.490) between the two groups. The estimated 5-year PFS rates were 67.0% (95%CI, 56.9%–75.7%) in the surgical staging group and 73.6% (95%CI, 67.4%–78.7%) in the clinical staging group. The corresponding 5-year OS rates were 76.3% (95%CI, 66.0%–83.9%) and 78.6% (95%CI, 72.7%–83.2%), respectively. Subgroup analysis stratified by imaging lymph node status demonstrated comparable survival outcomes. Multivariate analysis identified adenocarcinoma, pelvic wall involvement, and imaging-positive lymph nodes as independent risk factors for PFS; adenocarcinoma, adenosquamous carcinoma, pelvic wall involvement, and imaging-positive lymph nodes were independent predictors of OS. Conclusions Laparoscopic para-aortic and pelvic lymphadenectomy before chemoradiotherapy was not associated with improved PFS or OS in this retrospective cohort, Tumor histology, pelvic wall involvement, and imaging-positive lymph nodes were the main prognostic factors.

Read PDF

Similar papers

Review Open access Sep 2026

Surgical intervention contribute to survival for patients with para-aortic lymph node metastasis from colorectal cancer, a meta-analysis and systematic review

A comprehensive meta-analysis of survival outcomes in CRC patients with PALNM undergoing PALND compared with non-surgical management provides the most comprehensive evidence to date that PALND is associated with a significant survival benefit in selected CRC patients with PALNM.

Wan-Bin He, Jie Dan, Ming-Jie Zhu et al. · 0 citations
Sep 2026

Prognostic impact of systematic lymphadenectomy during interval debulking surgery after neoadjuvant chemotherapy in stage III ovarian cancer: A 38-institution retrospective cohort study using inverse probability of treatment weighting.

SyLND was associated with better PFS and OS in patients with stage III ovarian cancer undergoing IDS, and pre-NACT nodal assessment may help determine the indications for SyLND during IDS.

Y. Iida, M. Kobayashi-Kato, H. Noma et al. · 0 citations
Open access Oct 2026

Residual DCIS Versus No Residual Breast Tumor After Neoadjuvant Chemotherapy in ypN0 Breast Cancer: A Retrospective Clinical, MRI, and Survival Comparison

Background/Objectives: The prognostic significance of residual ductal carcinoma in situ (ypTis) compared with no residual tumor in the breast (ypT0) after neoadjuvant chemotherapy (NAC) remains uncertain. We compared clinicopathological, MRI, treatment, and survival outcomes between these groups. Methods: This single-c...

O. Mermut, Berrin Yalcın, R. Gürsu et al. · 0 citations
Open access Jul 2026

Association of regional lymph node resection with survival in patients with locally advanced-stage cervical cancer: A retrospective SEER-based cohort study

Objective This study aimed to validate the prognostic discriminatory power of the revised International Federation of Gynecology and Obstetrics (FIGO) 2018 staging system and to evaluate the association between regional lymph node resection (RLNR) and survival in cervical cancer (CC) patients who underwent RLNR followe...

Ai-Yuan Wu, R. Rezhake, Zi-Yin Huang et al. · 0 citations
Open access 2026

Association of lymphadenectomy extent with long-term survival in gastric cancer: a retrospective comparative cohort study

Introduction: The optimal extent of lymphadenectomy for gastric cancer remains controversial, particularly in Western practice, where concerns regarding postoperative morbidity have historically limited the wide-spread adoption of D2 dissection. This study aimed to compare the perioperative safety and long-term on-colo...

Huseyin Kocaaslan, Cengiz Ceylan, M. Güzel et al. · 0 citations
Review Open access Oct 2026

Retrospective Study of Pelvic Irradiation in Patients With Advanced Uterine Cervical Cancer

Background/Aim: The clinical role of local therapy for advanced uterine cervical cancer remains unclear. While systemic chemotherapy is the standard treatment, pelvic radiotherapy may contribute to local control and potentially improve outcomes in selected patients. This study aimed to evaluate the clinical significanc...

N. Utsumi, H. Kawamura, Takafumi Yamano et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.